Richard Goodfellow is chief executive of the UK biotech Scancell, which just secured a deal with the charity Cancer Research UK (CRUK) to take a therapeutic cancer vaccine into the clinic ...

CRH, which is the innovation arm of the charity Cancer Research UK (CRUK) operates as a clinical developer ‘with a twist’. It can offer the operational skills and network of scientific and ...

CRUK awards centre status to locations performing the highest quality cancer research and provides investment funding to develop that research Together with the Centre for Cancer Prevention at Queen ...